These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38895887)

  • 21. Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises.
    Hagedorn JM; Monico EC
    Pediatr Emerg Care; 2019 Jan; 35(1):78-79. PubMed ID: 27902670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily pain in adults with sickle cell disease-a different perspective.
    van Tuijn CF; Sins JW; Fijnvandraat K; Biemond BJ
    Am J Hematol; 2017 Feb; 92(2):179-186. PubMed ID: 27880985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal buprenorphine for the treatment of chronic noncancer pain in the oldest old.
    Gianni W; Madaio AR; Ceci M; Benincasa E; Conati G; Franchi F; Galetti G; Nieddu A; Salani B; Zuccaro SM
    J Pain Symptom Manage; 2011 Apr; 41(4):707-14. PubMed ID: 21145700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of pain due to sickle cell disease.
    Johnson L; Carmona-Bayonas A; Tick L
    J Pain Palliat Care Pharmacother; 2008; 22(1):51-4. PubMed ID: 19042824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal buprenorphine (Butrans) for chronic pain.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases.
    Schriek P
    Support Care Cancer; 2004 Dec; 12(12):882-4. PubMed ID: 15480815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland.
    Przeklasa-Muszynska A; Dobrogowski J
    Curr Med Res Opin; 2011 Jun; 27(6):1109-17. PubMed ID: 21456888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease.
    Knight LMJ; Onsomu EO; Bosworth HB; Crawford RD; DeMartino T; Glassberg J; Paice JA; Miller CN; Richardson L; Tanabe P
    Adv Emerg Nurs J; 2019; 41(1):86-97. PubMed ID: 30702538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine for the treatment of pain in sickle cell disease.
    Gupta M; Msambichaka L; Ballas SK; Gupta K
    ScientificWorldJournal; 2015; 2015():540154. PubMed ID: 25654130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perioperative Buprenorphine Management: A Multidisciplinary Approach.
    Hickey T; Abelleira A; Acampora G; Becker WC; Falker CG; Nazario M; Weimer MB
    Med Clin North Am; 2022 Jan; 106(1):169-185. PubMed ID: 34823729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain management in adults with sickle cell disease in a medical center emergency department.
    Solomon LR
    J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain.
    James IG; O'Brien CM; McDonald CJ
    J Pain Symptom Manage; 2010 Aug; 40(2):266-78. PubMed ID: 20541900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can pain studies influence regulatory policy?
    Embury SH
    Pain Med; 2011 May; 12(5):690-1. PubMed ID: 21564505
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
    Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises.
    Kelly GS; Stewart RW; Strouse JJ; Anders JF
    Am J Emerg Med; 2018 Jul; 36(7):1305-1307. PubMed ID: 29128141
    [No Abstract]   [Full Text] [Related]  

  • 37. [Analgesic management of acute pain in patients receiving methadone or buprenorphine].
    Zinck L; Sonne NM; Madsen SL; Nikolajsen L
    Ugeskr Laeger; 2015 Mar; 177(10):. PubMed ID: 25749118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
    Admiraal M; van Daalen J; Ritt MWJ; Dekker J; van Tuijn CFJ; Nur E; Hollmann MW; Hermanns H; Hermanides J; Biemond BJ
    Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine TTS for children--a review of the drug's clinical pharmacology.
    Michel E; Anderson BJ; Zernikow B
    Paediatr Anaesth; 2011 Mar; 21(3):280-90. PubMed ID: 21091589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.